Isolator Technology - Option 2

Donald Eddington, PhD, is a Technical Consultant with Eddington and Bond Associates is a Technical Consultant with Eddington and Bond Associates. His prior employment was with METALL+PLASTIC (M+P) as director of R&D, where he focused on isolators, aseptic processing and hydrogen peroxide decontamination. Prior to M+P, he held various positions at STERIS/AMSCO starting in 1991 as a senior engineer and rising to director of process engineering. His responsibilities included the development and application of hydrogen peroxide sterilization machinery. Eddington received his BS and ME from the University of Florida and his PhD degree from North Carolina State University.

Chris Smalley has recently retired from Merck, where he had responsibility for innovative implementation and validation, including Single Use Systems globally. He now is a consultant for Valsource, focused primarily on Compounding Pharmacies. Previously, he had been Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and validation activities globally.  His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier he had worked for the Johnson & Johnson family of companies, where he was a Plant Manager.

Chris retired after 21 years of service as a LtCol in the U.S. Air Force.  Chris practiced as a compounding pharmacist across the military hospital system, compounding intravenous solutions and total parenteral nutrition products to meet physicians' orders.  Chris is a graduate of the Philadelphia College of Pharmacy.  His graduate education includes a MBA from Temple University Fox School of Business, a Masters of Science in Pharmaceutical Chemistry from Temple University School of Pharmacy, and a PhD in Healthcare Administration from LaSalle University.

Chris has been a member of the PDA Board of Directors, as well as a member of the PDA Science Advisory Board.